Asmaa Tazi
Overview
Explore the profile of Asmaa Tazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charlier C, Anselem O, Caseris M, Lachatre M, Tazi A, Driessen M, et al.
Gynecol Obstet Fertil Senol
. 2025 Jan;
53(3):118-129.
PMID: 39805558
The Société de Pathologie Infectieuse de Langue Française released in 2024 a new national recommendation for clinical practice on the prevention and management of varicella zoster virus (VZV) infection during...
2.
Moing V, Bonnet E, Cattoir V, Chirouze C, Deconinck L, Duval X, et al.
Infect Dis Now
. 2024 Nov;
55(1):105011.
PMID: 39561877
No abstract available.
3.
Parpex G, Belan M, Tazi A, Campin L, Ganancia S, Canoui E, et al.
Fertil Steril
. 2024 Nov;
PMID: 39521112
No abstract available.
4.
Claverie C, Coppolino F, Mazzuoli M, Guyonnet C, Jacquemet E, Legendre R, et al.
Nat Commun
. 2024 Oct;
15(1):9175.
PMID: 39448655
Bacterial two-component systems (TCSs) are signaling modules that control physiology, adaptation, and host interactions. A typical TCS consists of a histidine kinase (HK) that activates a response regulator via phosphorylation...
5.
Micheli G, Parpex G, Tazi A, Holeindre E, Loubinoux J, Guyonnet C, et al.
J Infect
. 2024 Sep;
89(5):106253.
PMID: 39260624
No abstract available.
6.
Hong Tuan Ha A, Mammeri A, Plainvert C, Charfi R, Poyart C, Tazi A, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Aug;
43(11):2215-2219.
PMID: 39172287
The genomic comparison of two Klebsiella michiganensis clinical isolates recovered from the same patient, one resistant to piperacillin-tazobactam and intermediate to cefotaxime, the other resistant to ceftazidime but susceptible to...
7.
Aznar E, Strazielle N, Costa L, Poyart C, Tazi A, Ghersi-Egea J, et al.
Fluids Barriers CNS
. 2024 Aug;
21(1):66.
PMID: 39152442
Background: Group B Streptococcus (GBS) is the leading cause of neonatal meningitis responsible for a substantial cause of death and disability worldwide. The vast majority of GBS neonatal meningitis cases...
8.
Brissac T, Guyonnet C, Sadouni A, Hernandez-Montoya A, Jacquemet E, Legendre R, et al.
Microlife
. 2024 Jul;
5:uqae014.
PMID: 38993744
is among the few pathogens that have not developed resistance to ß-lactam antibiotics despite decades of clinical use. The molecular basis of this long-lasting susceptibility has not been investigated, and...
9.
Bourrel A, Picart A, Fernandez J, Hays C, Mignon V, Saubamea B, et al.
Infect Immun
. 2024 Jun;
92(7):e0018824.
PMID: 38869296
No abstract available.
10.
Sbaa G, Delettre N, Guyonnet C, Le Huu Nghia S, Joubrel-Guyot C, Plainvert C, et al.
J Infect Dis
. 2024 Jun;
231(2):329-333.
PMID: 38842059
Recurrence is a rare complication of group B Streptococcus (GBS) neonatal infections. We conducted a retrospective observational study on GBS neonatal invasive infections in France from 2007 to 2021. A...